St. Teresa Medical's Grant

St. Teresa Medical raised a round of funding on June 16, 2011. Investors include Minnesota Angel Tax Credit.

St. Teresa Medical has developed a technology namely Fastclot, which is developed from salmon-derived proteins to make a robust and inexpensive platform for hemostatic products that are ideal for both…

Articles about St. Teresa Medical's Grant: